These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17557312)

  • 1. Respiratory irregularity and stress hormones in panic disorder: exploring potential linkages.
    Abelson JL; Khan S; Lyubkin M; Giardino N
    Depress Anxiety; 2008; 25(10):885-7. PubMed ID: 17557312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL; Khan S; Liberzon I; Young EA
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No dynamic lung function abnormalities in panic disorder patients.
    Verburg K; de Leeuw M; Pols H; Griez E
    Biol Psychiatry; 1997 Apr; 41(7):834-6. PubMed ID: 9084904
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistent respiratory irregularity in patients with panic disorder.
    Abelson JL; Weg JG; Nesse RM; Curtis GC
    Biol Psychiatry; 2001 Apr; 49(7):588-95. PubMed ID: 11297716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A; Knyazhansky L; Loewenthal U; Arbelle J; Cohen H; Benjamin J
    Depress Anxiety; 2005; 21(3):143-8. PubMed ID: 16001448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic.
    Abelson JL; Nesse RM; Weg JG; Curtis GC
    Psychosom Med; 1996; 58(4):302-13. PubMed ID: 8827792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychophysiological reactions to two levels of voluntary hyperventilation in panic disorder.
    Wollburg E; Meuret AE; Conrad A; Roth WT; Kim S
    J Anxiety Disord; 2008 Jun; 22(5):886-98. PubMed ID: 17950571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tidal volume of respiration and "sighing" as indicators of breathing irregularities in panic disorder patients.
    Schwartz GE; Goetz RR; Klein DF; Endicott J; Gorman JM
    Anxiety; 1996; 2(3):145-8. PubMed ID: 9160616
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory feedback for treating panic disorder.
    Meuret AE; Wilhelm FH; Roth WT
    J Clin Psychol; 2004 Feb; 60(2):197-207. PubMed ID: 14724927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
    Masdrakis VG; Markianos M; Oulis P
    Psychiatry Res; 2015 Sep; 229(1-2):75-81. PubMed ID: 26243374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing breathing therapies for panic disorder: a randomized controlled trial of lowering vs raising end-tidal P(CO₂).
    Kim S; Wollburg E; Roth WT
    J Clin Psychiatry; 2012 Jul; 73(7):931-9. PubMed ID: 22901344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychophysiological assessment of respiratory function in panic disorder: evidence for a hyperventilation subtype.
    Hegel MT; Ferguson RJ
    Psychosom Med; 1997; 59(3):224-30. PubMed ID: 9178332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.
    Abelson JL; Curtis GC
    Arch Gen Psychiatry; 1996 Apr; 53(4):323-31. PubMed ID: 8634010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
    Jakuszkowiak-Wojten K; Landowski J; Wiglusz MS; Cubała WJ
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.
    Abelson JL; Nesse RM; Vinik AI
    Biol Psychiatry; 1994 Jul; 36(2):84-96. PubMed ID: 7524696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panic disorder and control of breathing.
    Nardi AE; Freire RC; Zin WA
    Respir Physiol Neurobiol; 2009 May; 167(1):133-43. PubMed ID: 18707030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopathological description of hyperventilation-induced panic attacks: a comparison with spontaneous panic attacks.
    Nardi AE; Lopes FL; Valença AM; Nascimento I; Mezzasalma MA; Zin WA
    Psychopathology; 2004; 37(1):29-35. PubMed ID: 14988648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels.
    Abelson JL; Curtis GC
    Am J Psychiatry; 1996 Jan; 153(1):69-73. PubMed ID: 8540595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.